Month: August 2020

Chennai, Mar 22, 2018: Caplin Point Laboratories Limited (BSE: CAPLL (524742),NSE: CAPLIPOINT) announced that Caplin Steriles Limited (a Wholly OwnedSubsidiary of Caplin Point Laboratories Ltd), has been granted final approval by the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Glycopyrrolate injection USP, 0.2mg/ml (in 1 ml, 2 ml,…

Read More »

– Caplin Steriles will out-license five of its injectable AND As to Baxter Healthcare Corporation . Chennai, April 08,2019: Caplin Point Laboratories Limited (BSE: CAPLL (524742), NSE:CAPLIPOINT) announced that Caplin Steriles Limited (a Wholly Owned Subsidiary of Caplin Point Laboratories Ltd) has entered into a license and supply agreement with Baxter Healthcare Corporation for five…

Read More »

20.09.2017Download

Read More »

08.05.2017Download

Read More »